Correlation Between GlaxoSmithKline PLC and Jpmorgan International

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Jpmorgan International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Jpmorgan International into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Jpmorgan International Unconstrained, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Jpmorgan International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Jpmorgan International. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Jpmorgan International.

Diversification Opportunities for GlaxoSmithKline PLC and Jpmorgan International

0.53
  Correlation Coefficient

Very weak diversification

The 3 months correlation between GlaxoSmithKline and Jpmorgan is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Jpmorgan International Unconst in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jpmorgan International and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Jpmorgan International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jpmorgan International has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Jpmorgan International go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Jpmorgan International

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Jpmorgan International. In addition to that, GlaxoSmithKline PLC is 1.48 times more volatile than Jpmorgan International Unconstrained. It trades about -0.23 of its total potential returns per unit of risk. Jpmorgan International Unconstrained is currently generating about 0.02 per unit of volatility. If you would invest  2,580  in Jpmorgan International Unconstrained on September 1, 2024 and sell it today you would earn a total of  7.00  from holding Jpmorgan International Unconstrained or generate 0.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy95.45%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Jpmorgan International Unconst

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Jpmorgan International 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Jpmorgan International Unconstrained has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Jpmorgan International is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

GlaxoSmithKline PLC and Jpmorgan International Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Jpmorgan International

The main advantage of trading using opposite GlaxoSmithKline PLC and Jpmorgan International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Jpmorgan International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jpmorgan International will offset losses from the drop in Jpmorgan International's long position.
The idea behind GlaxoSmithKline PLC ADR and Jpmorgan International Unconstrained pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Technical Analysis
Check basic technical indicators and analysis based on most latest market data